Learn about our new strategic partnership with SiSaf and how we are contributing to the next generation of targeted and controlled drug delivery
SiSaf is a pioneering UK-based bio-pharmaceutical company and the originator of its patented bio-courier, ProSilic®. ProSilic® is a novel drug delivery technology which was created to solve the fundamental limitations of a wide range of active pharmaceutical ingredients. It can improve efficacy, stability, solubility, bioavailability, release and route of administration.
ProSilic® is a fully biodegradable hybrid of porous elemental silicon (Si14), lipids and amino acids offering exceptional safety and versatility.
Together with SiSaf, Croda is giving customers access to the next generation of targeted and controlled drug delivery. This technology allows us to tailor our drug delivery solutions to specific customer needs, while offering exceptional safety and versatility.